Effects of cyclopofol and propofol on the incidence of intraoperative hypotension, postoperative memory, sleep quality, and anti-anxiety in patients with painless gastroenteroscopy : Multicentre, prospective, double-blind, randomized controlled study

Start Date01 Dec 2024

Sponsor / Collaborator

Qingdao Municipal Hospital

100 Clinical Results associated with Qingdao Municipal Hospital

0 Patents (Medical) associated with Qingdao Municipal Hospital

2,532

Literatures (Medical) associated with Qingdao Municipal Hospital

31 Dec 2025·Scandinavian Cardiovascular Journal

The efficacy of colchicine compared to placebo for preventing ischemic stroke among individuals with established atherosclerotic cardiovascular diseases: a systematic review and meta-analysis

Review

Author: Shi, Kai ; Zhu, Shulai ; Pan, Weiwei ; Yao, Yingjie

Background. Colchicine is an anti-inflammatory drug with promising efficacy for preventing cardiovascular events. We aimed to assess the pooled effect of colchicine on ischemic stroke among patients with established atherosclerotic cardiovascular diseases. Methods. PubMed, Scopus, Web of Science, and the Cochrane Library were systematically searched from the inception to August 5, 2024. A random-effects (DerSimonian-Laird) model was used to conduct this meta-analysis. The inclusion criteria were as follows: (I) being a randomized controlled trial; and (II) measuring the efficacy of colchicine compared to placebo for preventing ischemic stroke among those with established atherosclerotic cardiovascular diseases. Results. We identified 13 eligible clinical trials with 24900 participants. Colchicine significantly decreased the risk of ischemic stroke (relative risk (RR) 0.85, 95% confidence interval (CI) (0.72, 0.99), I²=2.92%) among those with established atherosclerotic cardiovascular diseases. Colchicine was more effective when used at 0.5 mg/day (RR 0.86, 95% CI (0.75, 0.99)), prescribed for more than 30 days (RR 0.86, 95% CI (0.75, 1.00)) or for more than 90 days (RR 0.65, 95% CI (0.46, 0.92)), or administered for patients with acute coronary syndrome (RR 0.46, 95% CI (0.23, 0.92)). In addition, colchicine was more effective in studies with a sample size of more than 500 patients, consistent with sensitivity analysis, which indicated that the results relied on large-sized clinical trials. Conclusion. Colchicine may decrease the risk of ischemic stroke among patients with established atherosclerotic cardiovascular diseases, particularly after long-term use; however, future studies are needed due to inconsistencies between existing trials.

01 Dec 2025·Immunologic Research

Irisin-mediated KEAP1 degradation alleviates oxidative stress and ameliorates pancreatitis

Article

Author: Chen, Zengyin ; Shang, Hezhen ; Shi, Guangjun ; Li, Wendi ; Yang, Zhen ; Tang, Nan

Oxidative stress (OS) injury is pivotal in acute pancreatitis (AP) pathogenesis, contributing to inflammatory cascades. Irisin, a ubiquitous cytokine, exhibits antioxidant properties. However, the role of irisin in AP remains inconclusive. Our study aims to elucidate irisin expression in AP patients and investigate its mechanism of action to propose a novel treatment strategy for AP. Serum irisin levels in 65 AP patients were quantified using an enzyme-linked immunosorbent assay and correlated with disease severity scores. Core genes implicated in AP-related oxidative stress were identified and screened via bioinformatics analysis. The therapeutic efficacy of irisin in AP was confirmed using a murine cerulein-induced AP model. The intrinsic mechanism of irisin's antioxidative stress action was investigated and verified in pancreatic AR42J cells (Supplementary Fig. 1). Common targets shared by irisin and AP were further validated using a molecular docking model which was constructed for virtual docking analysis. This study investigated alterations in redox status in AP and found a significant reduction in serum irisin levels, correlating inversely with AP severity. In a murine AP model, we showed that irisin triggers an antioxidative stress program via the KEAP1 gene; this process helps reestablish redox balance by decreasing the buildup of reactive oxygen species (ROS) and suppressing the secretion of inflammatory mediators within pancreatic tissues Notably, increased KEAP1 expression counteracted the antioxidative effects of irisin. Our findings unveil a novel therapeutic mechanism for AP, wherein irisin inhibits KEAP1 to alleviate OS. Increasing irisin levels in vivo presents a promising strategy for AP treatment.

01 Dec 2025·Transgenic Research

Exploring genetic mapping and co-expression patterns to illuminate significance of Tbx20 in cardiac biology

Article

Author: Niu, Li ; Ji, Quanquan ; Zhang, Dezhong ; Shang, Xiao

The transcription factor Tbx20 is integral to heart development and plays a significant role in various cardiac diseases. Despite its established importance, the regulatory mechanisms and functional significance of Tbx20 remain incompletely understood. To elucidate these mechanisms, we initially conducted eQTL mapping to identify genetic loci associated with Tbx20 expression in heart tissue from BXD mice. Co-expression and enrichment analyses revealed pathways linked to Tbx20, including dilated cardiomyopathy, hypertrophic cardiomyopathy, and FoxO signaling. Additionally, protein-protein interaction studies identified essential cardiac proteins, such as Myl2 and Myl7, along with upstream regulators like Mef2c. To validate our bioinformatic findings, we performed quantitative reverse transcription polymerase chain reaction (qRT-PCR) to assess the relative mRNA expression levels of TBX20 and Mef2c in the heart tissues of BXD mice compared to their parental strains (B6 and D2). Our results demonstrated significant up-regulation of both TBX20 and Mef2c in the BXD group relative to the parental strains. Conversely, both genes were down-regulated in B6, D2, Control, and Treatment groups when compared to BXD mice. These findings confirm the predicted regulatory roles of TBX20 and Mef2c in cardiac development as suggested by our initial analyses.This study not only reinforces the critical role of Tbx20 in cardiac gene regulation but also highlights its potential as a therapeutic target for cardiovascular disorders. Further investigations into Tbx20 and its interactions will enhance our understanding of heart biology and contribute to the development of targeted therapies for heart diseases.

News (Medical) associated with Qingdao Municipal Hospital

10 Jan 2025

·www.drugs.com

Epilepsy Associated With Poor Brain Health

FRIDAY, Jan. 10, 2025 -- Epilepsy is associated with poor brain health, with a consistent deleterious effect seen on cognitive and motor function and mental health, according to a study published online Dec. 31 in the Journal of Translational Medicine . Dan-Dan Zhang, from Qingdao Municipal Hospital at Qingdao University in China, and colleagues examined the relationship of epilepsy with brain function, other common brain disorders, and their underlying mechanisms using data from 426,527 participants in the U.K. Biobank, 3,251 of whom were diagnosed with epilepsy at baseline. The researchers found that epilepsy had consistent deleterious effects on cognitive and motor function and mental health. During the 17-year follow-up period, the population with epilepsy had a significantly elevated risk for neurological diseases and psychiatric disorders , according to the longitudinal analysis. Several brain regions associated with epilepsy were identified, including the pallidum, hippocampus, and precentral regions. Mediating effects were seen for peripheral markers and proteins (e.g., GGT, HDL, ACE2, and GDF15), suggesting the involvement of liver function and lipid metabolism in the development of brain disorders in individuals with epilepsy. "Our study emphasized the importance of early intervention in the diagnosis and treatment of epilepsy for brain health, and provided new insights to improve the quality of survival of patients with epilepsy," the authors write. Abstract/Full Text Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

100 Deals associated with Qingdao Municipal Hospital

100 Translational Medicine associated with Qingdao Municipal Hospital

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 23 Jan 2025

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Qingdao Municipal Hospital

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 23 Jan 2025

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing